Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) reported upbeat second-quarter earnings and 2025 guidance on Thursday. The company ...

Lenz Therapeutics has earned the FDA’s go-ahead for its aceclidine eye drop to crack the large presbyopia market, where past ...

Despite the overall decline in commercial product revenue, Moderna was also pleasantly surprised by Q2 Spikevax sales, which ...

In CCC v AAC [2025] HKCFI 2987, Sir William Blair, sitting as Deputy High Court Judge in the Hong Kong Court of First Instance (“Court”), rejected ...

Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.

IBS Intelligence (IBSi) is the world’s only pure-play Financial Technology focused research, advisory, and fintech news ...

Global stocks weakened on Friday morning after US President Donald Trump hit multiple countries with a blitz of tariffs.

The all-cash deal could allow Verisk to simplify interactions between insurers and contractors, which it says will speed up claims and lower expenses for policyholders. Roofing is one of the most ...

Operator: Ladies and gentlemen, good morning, and welcome to the Proto Labs Second Quarter 2025 Earnings Conference Call.

The Antitrust & Competition Economics practice set a new quarterly revenue high, supported by merger activity and demand for antitrust services. Maleh pointed to the team's role in Hewlett Packard ...

"Wipfli has been on the offensive, scaling smartly and profitably. And now, we're accelerating the course we already set with this investment," said Kurt Gresens, Managing Partner of Wipfli. "New ...

Palantir stock dipped on Friday as analysts mulled possible upside from a revised U.S. Army deal and equities sold off on ...